FMO2 and breast carcinoma: In addition, we excavated secreted Frizzled-related protein 1 (SFRP1), a known negative regulator of the Wnt/β-catenin pathway [12], from the perspective of co-expression analysis to reveal the potential molecular mechanism of FMO2 in breast cancer.